226 related articles for article (PubMed ID: 21347234)
21. Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens.
Gómez CE; Nájera JL; Sánchez R; Jiménez V; Esteban M
Vaccine; 2009 May; 27(24):3165-74. PubMed ID: 19446187
[TBL] [Abstract][Full Text] [Related]
22. Immune Modulation of NYVAC-Based HIV Vaccines by Combined Deletion of Viral Genes that Act on Several Signalling Pathways.
Gómez CE; Perdiguero B; Sánchez-Corzo C; Sorzano COS; Esteban M
Viruses; 2017 Dec; 10(1):. PubMed ID: 29280955
[TBL] [Abstract][Full Text] [Related]
23. Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens.
Nájera JL; Gómez CE; García-Arriaza J; Sorzano CO; Esteban M
PLoS One; 2010 Jun; 5(6):e11406. PubMed ID: 20613977
[TBL] [Abstract][Full Text] [Related]
24. Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.
Asbach B; Kliche A; Köstler J; Perdiguero B; Esteban M; Jacobs BL; Montefiori DC; LaBranche CC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Landucci G; Forthal DN; Seaman MS; Hawkins N; Self SG; Sato A; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Francis J; Galmin L; Ding S; Heeney JL; Pantaleo G; Wagner R
J Virol; 2016 Apr; 90(8):4133-4149. PubMed ID: 26865719
[TBL] [Abstract][Full Text] [Related]
25. Distinct Roles of Vaccinia Virus NF-κB Inhibitor Proteins A52, B15, and K7 in the Immune Response.
Di Pilato M; Mejías-Pérez E; Sorzano COS; Esteban M
J Virol; 2017 Jul; 91(13):. PubMed ID: 28424281
[TBL] [Abstract][Full Text] [Related]
26. Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responses.
Didierlaurent A; Ramirez JC; Gherardi M; Zimmerli SC; Graf M; Orbea HA; Pantaleo G; Wagner R; Esteban M; Kraehenbuhl JP; Sirard JC
Vaccine; 2004 Sep; 22(25-26):3395-403. PubMed ID: 15308364
[TBL] [Abstract][Full Text] [Related]
27. Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag-specific immune response in mice.
Maamary J; Array F; Gao Q; García-Sastre A; Steinman RM; Palese P; Nchinda G
J Virol; 2011 Mar; 85(5):2235-46. PubMed ID: 21159873
[TBL] [Abstract][Full Text] [Related]
28. A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses.
García-Arriaza J; Nájera JL; Gómez CE; Tewabe N; Sorzano CO; Calandra T; Roger T; Esteban M
PLoS One; 2011; 6(8):e24244. PubMed ID: 21909386
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity of Semliki Forest virus based self-amplifying RNA expressing Indian HIV-1C genes in mice.
Ajbani SP; Velhal SM; Kadam RB; Patel VV; Bandivdekar AH
Int J Biol Macromol; 2015 Nov; 81():794-802. PubMed ID: 26361864
[TBL] [Abstract][Full Text] [Related]
30. Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques.
Lorin C; Vanloubbeeck Y; Baudart S; Ska M; Bayat B; Brauers G; Clarinval G; Donner MN; Marchand M; Koutsoukos M; Mettens P; Cohen J; Voss G
PLoS One; 2015; 10(4):e0122835. PubMed ID: 25856308
[TBL] [Abstract][Full Text] [Related]
31. Highly attenuated HIV type 2 recombinant poxviruses, but not HIV-2 recombinant Salmonella vaccines, induce long-lasting protection in rhesus macaques.
Franchini G; Robert-Guroff M; Tartaglia J; Aggarwal A; Abimiku A; Benson J; Markham P; Limbach K; Hurteau G; Fullen J
AIDS Res Hum Retroviruses; 1995 Aug; 11(8):909-20. PubMed ID: 7492438
[TBL] [Abstract][Full Text] [Related]
32. Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8(+) T cell responses in HIV-1-infected individuals.
Climent N; Guerra S; García F; Rovira C; Miralles L; Gómez CE; Piqué N; Gil C; Gatell JM; Esteban M; Gallart T
PLoS One; 2011; 6(5):e19644. PubMed ID: 21625608
[TBL] [Abstract][Full Text] [Related]
33. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses.
Harari A; Bart PA; Stöhr W; Tapia G; Garcia M; Medjitna-Rais E; Burnet S; Cellerai C; Erlwein O; Barber T; Moog C; Liljestrom P; Wagner R; Wolf H; Kraehenbuhl JP; Esteban M; Heeney J; Frachette MJ; Tartaglia J; McCormack S; Babiker A; Weber J; Pantaleo G
J Exp Med; 2008 Jan; 205(1):63-77. PubMed ID: 18195071
[TBL] [Abstract][Full Text] [Related]
34. Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.
Guerra S; Nájera JL; González JM; López-Fernández LA; Climent N; Gatell JM; Gallart T; Esteban M
J Virol; 2007 Aug; 81(16):8707-21. PubMed ID: 17537851
[TBL] [Abstract][Full Text] [Related]
35. Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
Garber DA; O'Mara LA; Zhao J; Gangadhara S; An I; Feinberg MB
PLoS One; 2009; 4(5):e5445. PubMed ID: 19421328
[TBL] [Abstract][Full Text] [Related]
36. Expression of vaccinia E3L and K3L genes by a novel recombinant canarypox HIV vaccine vector enhances HIV-1 pseudovirion production and inhibits apoptosis in human cells.
Fang ZY; Limbach K; Tartaglia J; Hammonds J; Chen X; Spearman P
Virology; 2001 Dec; 291(2):272-84. PubMed ID: 11878896
[TBL] [Abstract][Full Text] [Related]
37. Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS.
Guerra S; González JM; Climent N; Reyburn H; López-Fernández LA; Nájera JL; Gómez CE; García F; Gatell JM; Gallart T; Esteban M
J Virol; 2010 Aug; 84(16):8141-52. PubMed ID: 20534857
[TBL] [Abstract][Full Text] [Related]
38. A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine.
Hel Z; Johnson JM; Tryniszewska E; Tsai WP; Harrod R; Fullen J; Tartaglia J; Franchini G
Vaccine; 2002 Aug; 20(25-26):3171-86. PubMed ID: 12163269
[TBL] [Abstract][Full Text] [Related]
39. Deletion of specific immune-modulatory genes from modified vaccinia virus Ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques.
Garber DA; O'Mara LA; Gangadhara S; McQuoid M; Zhang X; Zheng R; Gill K; Verma M; Yu T; Johnson B; Li B; Derdeyn CA; Ibegbu C; Altman JD; Hunter E; Feinberg MB
J Virol; 2012 Dec; 86(23):12605-15. PubMed ID: 22973033
[TBL] [Abstract][Full Text] [Related]
40. Equivalent immunogenicity of the highly attenuated poxvirus-based ALVAC-SIV and NYVAC-SIV vaccine candidates in SIVmac251-infected macaques.
Hel Z; Nacsa J; Tsai WP; Thornton A; Giuliani L; Tartaglia J; Franchini G
Virology; 2002 Dec; 304(1):125-34. PubMed ID: 12490410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
